Xi'an Taikomed Pharmaceutical Technology Co., Ltd. (Taikomed) is a prominent Contract Research Organization (CRO) based in Northwest China. Founded in 2011, the company specializes in providing comprehensive technical services and technology transfer for pharmaceutical enterprises, hospitals, and research institutions. Their core expertise spans chemical APIs, drug formulations, traditional Chinese medicine (TCM), and innovative medical devices.
The company focuses on supporting the entire drug development lifecycle, including innovative drug R&D, generic drug development, and consistency evaluation. Taikomed operates as a technology-driven service provider, facilitating the transformation of research into commercial applications within the Chinese pharmaceutical market.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:2011
Ownership:private
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service provider)
Modalities:Small molecule, TCM
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
LINKS
Website:taikomed.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Xi'an Taikomed Pharmaceutical Technology Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Xi'an Taikomed Pharmaceutical Technology Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.